… Although their first application in clinical practice occurred in the 1940s, vitamin K
antagonists remain the only form of oral anticoagulant medication approved for long-term use. …

… in the safety of pharmacologic drugs. There is paucity of data for direct oral anticoagulants
(… The primary and secondary objectives of this study were to assess the safety and efficacy of …

… Use of oral anticoagulants (OACs) with vitamin K antagonists (VKAs) or direct oral anticoagulants
… In this study, we aimed to investigate the efficacy and safety of treatment with DOACs in …

… anticoagulants despite their higher risk of stroke compared with men. Objective: To evaluate
whether the efficacy and safety of direct oral anticoagulants (… the safety and efficacy of …

… was safe (1). Accordingly, we hypothesized that continuation of oral anticoagulation before
and after transfemoral TAVR is equally safe and efficacious compared with interruption of …

Background DOACs are increasingly used in patients with NVAF. Information on efficacy
and safety of these compounds in patients undergoing electrical or pharmacological …

… The safety of direct oral anticoagulants (DOACs) in patients after solid organ transplantation
(SOT) is not well defined. This study aimed at describing the safety and efficacy of DOACs in …

… safety concern with all of these drugs—as it is with the more established oral anticoagulant
… Postmarketing surveillance studies (PMSS) provide the opportunity to evaluate the safety of …

… Much direct evidence has proved that the novel oral anticoagulants (NOACs) are noninferior
or … The current study is a network meta-analysis aiming to assess the efficacy and safety of …

… The aim was to perform a review of the efficacy and safety of new oral anticoagulants (NOAs…
Safety and net clinical benefit of new oral anticoagulants (NOAs) in the treatment of venous …